Minocycline-based combination therapy has been suggested to be a possible choice for the
treatment of infections caused by minocycline-susceptible Acinetobacter baumannii, but its …

Antimicrobial resistance among Acinetobacter baumannii is increasing worldwide, often
necessitating combination therapy. The clinical utility of using minocycline with polymyxin B …

Minocycline (MIN) usually shows good activity against Acinetobacter baumannii strains. The
reintroduction to the market of intravenous MIN provides an additional agent to the limited …

Acinetobacter baumannii can cause life-threatening nosocomial infections associated with
high rates of morbidity and mortality. In recent years, the increasing number of infections due …

Multidrug-resistant (MDR) Acinetobacter baumannii is increasingly more prevalent in
nosocomial infections. Although in vitro susceptibility of A. baumannii to minocycline is …

Early studies in the 1970s showed that minocycline was an effective antibiotic for the
treatment of Acinetobacter-associated infections. At that time, most Acinetobacter baumannii …

Background Antimicrobial Stewardship Programs should consider old antimicrobials for
emerging multidrug-resistant (MDR) organisms such as Acinetobacter baumannii. Our …

Objectives The study investigated the effect of colistin and minocycline when tested singly
and in combination against Acinetobacter baumannii. Methods Thirteen unrelated imipenem …

Among Acinetobacter species, A. baumannii and other closely related species are
commonly implicated in nosocomial infections. These organisms are usually multidrug …

Background Infections sustained by multidrug-resistant (MDR) and pan-resistant
Acinetobacter baumannii have become a challenging problem in Intensive Care Units …